Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Acelyrin
Acelyrin
Acelyrin shifts from main drug, lays off staff
BioPharma Dive
Tue, 08/13/24 - 11:03 pm
Acelyrin
layoffs
izokibep
lonigutamab
thyroid eye disease
Biopharma’s top 5 IPOs of 2023 (so far)
Pharma Voice
Thu, 11/30/23 - 10:01 am
biotech
IPOs
Acelyrin
Apogee Therapeutics
RayzeBio
Neumora Therapeutics
Mineralys Therapeutics
Fresh from IPO, Acelyrin's lead drug fails clinical trial
Pharmaphorum
Tue, 09/12/23 - 12:02 pm
Acelyrin
clinical trials
izokibep
hidrad
7 Life Science IPOs in 2023
BioSpace
Wed, 07/12/23 - 09:48 am
IPOs
Intensity Therapeutics
Acelyrin
CytoMed Therapeutics
Mineralys Therapeutics
Structure Therapeutics
Genelux
Cadrenal Therapeutics
Biophama's flotation haul creeps higher
EP Vantage
Thu, 07/6/23 - 10:09 am
IPOs
biotech
Acelyrin
Apogee Therapeutics
Azitra
CytoMed Therapeutics
Intensity Therapeutics
Mineralys Therapeutics
Paragon Therapeutics
Sagimet Biosciences
Structure Therapeutics
Turnstone Biologics
Acelyrin makes a splash with IPO, biopharma expects to raise $540M
Medical Marketing and Media
Sun, 05/7/23 - 10:16 pm
Acelyrin
IPOs
Acelyrin follows Kenvue with largest IPO for a biotech startup since 2021
BioPharma Dive
Fri, 05/5/23 - 12:08 pm
Acelyrin
IPOs
Kenvue
IPO Market Shows Signs of Life as Acelyrin Begins Nasdaq Bid
BioSpace
Sun, 04/16/23 - 11:10 pm
Acelyrin
IPOs
immunology
AAD 2023 – UCB and Acelyrin take aim at hidradenitis suppurativa
EP Vantage
Tue, 03/21/23 - 09:54 am
AAD
hidradenitis suppurativa
AbbVie
Humira
UCB Pharma
Bimzelx
Acelyrin
izokibep
Acelyrin raises $250M, licenses antibody drug that could rival Novartis, Lilly meds
MedCity News
Tue, 11/16/21 - 10:31 am
Acelyrin
Affibody
antibodies
monoclonal antibodies
immunology
Novartis
Eli Lilly